Regentis Biomaterials RGNT
NYSE RGNT
$2.06 -0.14 (-6.36%)
At close: Aug 20, 2026 · 4:00 PM EDT

Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025)

Regentis Biomaterials (RGNT) posted quarterly Debt Ratio of 0.16 for Q4 2025, down 86.78% year-over-year from 1.19 in Q4 2024, and down 86.78% quarter-over-quarter from 1.19 in Q4 2024.

Regentis Biomaterials (RGNT) Debt Ratio (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has reported Debt Ratio for 2 consecutive years, with 0.16 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Debt Ratio fell 86.78% year-over-year to 0.16; the TTM figure through Dec 2025 stood at 0.16 (down 86.78% YoY), while the FY2025 annual figure was 0.16, down 86.78% from the prior year.
  • Debt Ratio fell to 0.16 in Q4 2025 per RGNT's latest filing, from 1.19 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.19 in Q4 2024 and bottomed at 0.16 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Intuitive Surgical 132.71 Bn 127.50 Bn 1.96 Bn -
2 Becton Dickinson 51.57 Bn 50.71 Bn 2.32 Bn 0.33
3 Alcon 35.52 Bn 34.17 Bn 1.68 Bn 0.15
4 Resmed 33.28 Bn 31.81 Bn 861.22 Mn 0.07
5 Medline 27.86 Bn 25.18 Bn 2.22 Bn 0.32
6 West Pharmaceutical Services 25.15 Bn 24.71 Bn 329.20 Mn 0.05
7 Solventum 15.31 Bn 14.91 Bn 1.29 Bn 0.36
8 Cooper Companies 14.86 Bn 14.72 Bn 735.40 Mn 0.20
9 Baxter International 13.63 Bn 11.48 Bn 1.03 Bn 0.48
10 Regentis Biomaterials 1.20 Mn -6.18 Mn - 0.16

Historic Data

Download Data
DateValue
Dec 31, 2025 0.16
Dec 31, 2024 1.19